Market Abuse Regulation ("MAR") Disclosure
This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) 596/2014 as it forms part of
01 November 2024
Bushveld Minerals Limited
("Bushveld" or the "Company")
Vanchem Sale Update
Bushveld Minerals (AIM: BMN), the AIM quoted, integrated primary vanadium producer, is pleased to announce that, further to the interim results announcement of 17 September 2024 and the proposed conditional disposal of Vanchem announcement of 07 May 2024, all conditions relating to the sale of the Vanchem vanadium processing plant, including Competition Tribunal approval, have now been met with final agreements being entered into on 31 October 2024. The transaction closed on the 31st of October and will become effective on Thursday, 07 November 2024.
Craig Coltman, CEO of Bushveld Minerals Limited, commented:
"With the Competition Tribunal's approval and all conditions now satisfied, the sale of Vanchem represents an important step in our efforts to create a more resilient business."
Financial Information relating to Vanchem
For the year ended 31 December 2023, Vanchem reported sales of
Enquiries : info@Bushveldminerals.com
Bushveld Minerals Limited |
|
+27 (0) 11 268 6555 |
Craig Coltman, Chief Executive Officer |
|
|
|
|
|
|
|
|
SP Angel Corporate Finance LLP |
Nominated Adviser & Joint Broker |
+44 (0) 20 3470 0470 |
Richard Morrison / Charlie Bouverat |
|
|
Grant Barker / Abigail Wayne |
|
|
|
|
|
Hannam & Partners |
Joint Broker |
+44 (0) 20 7907 8500 |
Andrew Chubb / Matt Hasson / Jay Ashfield |
|
|
|
|
|
Tavistock |
Financial PR |
+44 (0) 207 920 3150 |
Gareth Tredway / Tara Vivian-Neal / James Whitaker |
|
|
ENDS
ABOUT BUSHVELD MINERALS LIMITED
Bushveld Minerals is a primary vanadium producer. It is one of the world's three primary vanadium producers, offering compelling exposure to vanadium through its upstream asset.
Detailed information on the Company and progress to date can be accessed on the website www.bushveldminerals.com
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.